Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1979 Dec;55(650):862–867. doi: 10.1136/pgmj.55.650.862

Diuretic-induced renal impairment without volume depletion in cirrhosis: changes in the renin-angiotensin system and the effect of β-adrenergic blockade

S P Wilkinson, M Bernardi, P G Wheeler, I K Smith, R Williams
PMCID: PMC2425705  PMID: 44911

Abstract

In 4 patients with cirrhosis and ascites, diuretic therapy resulted in an impairment of renal function that was associated with a rise in plasma renin activity (PRA). In 3, this occurred in the absence of volume depletion. When diuretics were discontinued, renal function returned to normal. β-adrenergic blocking drugs were then given to suppress renin secretion and diurectics restarted. On this occasion, impairment of renal function did not occur. In 2 further patients, administration of β-adrenergic blockers during a period of diuretic-induced renal impairment resulted in an improvement in renal function. Although these findings may indicate that diuretic-induced renal impairment in cirrhosis is at least partly due to activation of the renin-angiotensin system, in another group of patients a diuretic-induced rise in PRA was not associated with a deterioration in renal function.

Full text

PDF
862

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bravo E. L., Tarazi R. C., Dustan H. P. Beta-adrenergic blockade in diuretic-treated patients with essential hypertension. N Engl J Med. 1975 Jan 9;292(2):66–70. doi: 10.1056/NEJM197501092920203. [DOI] [PubMed] [Google Scholar]
  2. Clemente C., Bosch J., Rodés J., Arroyo V., Mas A., Maragall S. Functional renal failure and haemorrhagic gastritis associated with endotoxaemia in cirrhosis. Gut. 1977 Jul;18(7):556–560. doi: 10.1136/gut.18.7.556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davis J. O., Freeman R. H. Mechanisms regulating renin release. Physiol Rev. 1976 Jan;56(1):1–56. doi: 10.1152/physrev.1976.56.1.1. [DOI] [PubMed] [Google Scholar]
  4. Duarte C. G., Chomety F., Giebisch G. Effect of amiloride, ouabain, and furosemide on distal tubular function in the rat. Am J Physiol. 1971 Aug;221(2):632–640. doi: 10.1152/ajplegacy.1971.221.2.632. [DOI] [PubMed] [Google Scholar]
  5. Eliahou H. E., Iaina A., Solomon S., Gavendo S. Alleviation of anoxic experimental acute renal failure in rats by beta-adrenergic blockade. Nephron. 1977;19(3):158–166. doi: 10.1159/000180881. [DOI] [PubMed] [Google Scholar]
  6. Gutman R. A., Forrey A. W., Fleet W. P., Cutler R. E. Vasopressor-induced natriuresis and altered intrarenal haemodynamics in cirrhotic man. Clin Sci. 1973 Jul;45(1):19–34. doi: 10.1042/cs0450019. [DOI] [PubMed] [Google Scholar]
  7. Hierholzer K., Stolte H. The proximal and distal tubular action of adrenal steroids on Na reabsorption. Nephron. 1969;6(3):188–204. doi: 10.1159/000179728. [DOI] [PubMed] [Google Scholar]
  8. Imbs J. L., Schmidt M., Velly J., Schwartz J. Comparison of the effect of two groups of diuretics on renin secretion in the anaesthetized dog. Clin Sci Mol Med. 1977 Feb;52(2):171–182. doi: 10.1042/cs0520171. [DOI] [PubMed] [Google Scholar]
  9. Karlberg B. E., Kågedal B., Tegler L., Tolagen K., Bergman B. Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity. Am J Cardiol. 1976 Mar 31;37(4):642–649. doi: 10.1016/0002-9149(76)90409-4. [DOI] [PubMed] [Google Scholar]
  10. Laragh J. H., Cannon P. J., Bentzel C. J., Sicinski A. M., Meltzer J. I. ANGIOTENSIN II, NOREPINEPHRINE, AND RENAL TRANSPORT OF ELECTROLYTES AND WATER IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES. J Clin Invest. 1963 Jul;42(7):1179–1192. doi: 10.1172/JCI104803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Leonetti G., Mayer G., Morganti A., Terzoli L., Zanchetti A., Bianchetti G., Di Salle E., Morselli P. L., Chidsey C. A. Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. Clin Sci Mol Med Suppl. 1975 Jun;48(6):491–499. doi: 10.1042/cs0480491. [DOI] [PubMed] [Google Scholar]
  12. Lieberman F. L., Ito S., Reynolds T. B. Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis. J Clin Invest. 1969 Jun;48(6):975–981. doi: 10.1172/JCI106078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lieberman F. L., Reynolds T. B. Renal failure with cirrhosis. Observations on the role of diuretics. Ann Intern Med. 1966 Jun;64(6):1221–1228. doi: 10.7326/0003-4819-64-6-1221. [DOI] [PubMed] [Google Scholar]
  14. Mogil R. A., Itskovitz H. D., Russell J. H., Murphy J. J. Renal innervation and renin activity in salt metabolism and hypertension. Am J Physiol. 1969 Apr;216(4):693–697. doi: 10.1152/ajplegacy.1969.216.4.693. [DOI] [PubMed] [Google Scholar]
  15. Rodés J., Bosch J., Arroyo V. Clinical types and drug therapy of renal impairment in cirrhosis. Postgrad Med J. 1975 Aug;51(598):492–497. doi: 10.1136/pgmj.51.598.492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schnermann J., Ploth D. W., Hermle M. Activation of tubulo-glomerular feedback by chloride transport. Pflugers Arch. 1976 Apr 6;362(3):229–240. doi: 10.1007/BF00581175. [DOI] [PubMed] [Google Scholar]
  17. Schroeder E. T., Anderson G. H., Goldman S. H., Streeten D. H. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis. Kidney Int. 1976 Jun;9(6):511–519. doi: 10.1038/ki.1976.65. [DOI] [PubMed] [Google Scholar]
  18. Shear L., Ching S., Gabuzda G. J. Compartmentalization of ascites and edema in patients with hepatic cirrhosis. N Engl J Med. 1970 Jun 18;282(25):1391–1396. doi: 10.1056/NEJM197006182822502. [DOI] [PubMed] [Google Scholar]
  19. Wernze H., Spech H. J., Müller G. Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver. Klin Wochenschr. 1978 Apr 15;56(8):389–397. doi: 10.1007/BF01477293. [DOI] [PubMed] [Google Scholar]
  20. Wilkinson S. P., Bernardi M., Smith I. K., Jowett T. P., Slater J. D., Williams R. Effect of beta adrenergic blocking drugs on the renin-aldosterone system, sodium excretion, and renal hemodynamics in cirrhosis with ascites. Gastroenterology. 1977 Oct;73(4 Pt 1):659–663. [PubMed] [Google Scholar]
  21. Wilkinson S. P., Moodie H., Stamatakis J. D., Kakkar V. V., Williams R. Endotoxaemia and renal failure in cirrhosis and obstructive jaundice. Br Med J. 1976 Dec 11;2(6049):1415–1418. doi: 10.1136/bmj.2.6049.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wilkinson S. P., Smith I. K., Clarke M., Arroyo V., Richardson J., Moodie H., Williams R. Intrarenal distribution of plasma flow in cirrhosis as measured by transit renography: relationship with plasma renin activity, and sodium and water excretion. Clin Sci Mol Med. 1977 May;52(5):469–475. doi: 10.1042/cs0520469. [DOI] [PubMed] [Google Scholar]
  23. Winer N., Chokshi D. S., Yoon M. S., Freedman A. D. Adrenergic receptor mediation of renin secretion. J Clin Endocrinol Metab. 1969 Sep;29(9):1168–1175. doi: 10.1210/jcem-29-9-1168. [DOI] [PubMed] [Google Scholar]
  24. Wright F. S., Briggs P. Feedback regulation of glomerular filtration rate. Am J Physiol. 1977 Jul;233(1):F1–F7. doi: 10.1152/ajprenal.1977.233.1.F1. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES